Bryan Gammon, MD, MBA, FAAD

BOARD-CERTIFIED DERMATOLOGIST AND DERMATOPATHOLOGIST
Dr. Bryan Gammon

Dr. Bryan Gammon is board certified in dermatology, dermatopathology, and micrographic dermatologic surgery by the American Board of Dermatology. After earning his medical degree in 2008 from the University of Texas Southwestern in Dallas, he completed his dermatology residency training at Northwestern University in Chicago, IL, serving as Co-Chief Resident. Dr. Gammon then pursued additional sub-specialty training with a dermatopathology Fellowship from Stanford University (Stanford, CA).

Dr. Gammon received an MBA from the University of California Los Angeles – Anderson School of Management in 2017. After his studies, he founded several practices, including Precision Dermatopathology, Juniper Dermatology, and Luminous Dermatology.

Dr. Gammon’s extensive professional experience and training are a welcomed asset to the Sagis team. He holds various honors, awards, and merits and has participated in dozens of peer-review publications, book chapter writings, poster and oral presentations, and lectureships.

Education

Fellowship Training

Dermatopathology
Stanford University
Stanford, CA

Residency Training

Dermatology
Northwestern University, Department of Dermatology
Evanston, IL

Internal Medicine
Tulane University, Department of Internal Medicine
New Orleans, LA

Medical School

University of Texas
Austin, TX

Undergraduate

University of Texas
Austin, TX

Board Certifications

Mohs Micrographic Surgery

The American Board of Dermatology

Dermatopathology

The American Board of Dermatology

Anatomic & Clinical Pathology

The American Board of Dermatology

Memberships

Research & Publications

Publications
  • Johnson RC, Kim J, Natkunam Y, Sundram U, Freud AG, Gammon B, Cascio MJ, Myeloid Cell Nuclear Differentiation Antigen (MNDA) Expression Distinguishes Extramedullary Presentations of Myeloid Leukemia From Blastic Plasmacytoid Dendritic Cell Neoplasm. Am J Surg Pathol 2106 Jan 19 [Epub]
  • Gammon B., Robson A., Arkin L., et al., Granulomatous Cytotoxic T cell lymphoma: a potential association with immunodeficiency. J Amer Acad Dermatol 2014 Sept; 71(3): 555-60.
  • Gammon B., Longmire M., DeClerck B., Intravascular crystal deposition: an early clue to the diagnosis of type I cryoglobulinemic vasculitis. Amer J Dermatopathol 2014 Sep;36(9):751-5.
  • Shain A, Gammon B, Mueller C, Kim J., Striated muscle hamartoma presenting as a chin cyst in a newborn. Dermatol Online J. 2014 Jul 15;20(7).
  • Gammon B., Traczyk T., Gerami P., Clumped perinuclear BAP1 expression is a frequent finding in sporadic epithelioid spitz tumors. J Cutan Pathol. 2013 Jun;40(6):538-42.
  • Guitart J., Gammon B., The Difficulties in defining Follicular T helper phenotype in Cutaneous Lymphomas. Amer J Dermatopathol. 2013 Jan 17 (Epub ahead of press).
  • Gammon B., Cotliar J., Viral infection as a trigger in flares of acute graft-versus-host disease. British J Dermatol 2013 Apr;168(4):906-8
  • Fathi R., Kamalpour L., Gammon B., et al., A novel treatment approach for extensive, eruptive, cutaneous squamous cell carcinomas in a patient receiving BRAF-inhibitor therapy for metastatic melanoma. Dermatol Surg 2013 Feb;39(2):341-4.
  • Gammon B., Gerami P., Utility of Fluorescence in situ Hybridization in Ambiguous Melanocytic Tumors. Histol Histopathol. 2012 Dec;27(12):1539-1542.
  • Gammon B., Guitart J., Intertriginous mycosis fungoides: a distinct presentation of cutaneous T cell lymphoma that may be caused by malignant T follicular helper cells. Arch Dermatol. 2012 Sep 1;148(9):1040-4.
  • Gammon B., Ali L., Guitart J., Gerami P., Homogeneous staining regions for Cyclin D1, a marker of poor prognosis in malignant melanoma. Amer J Dermatopathol. 2012 Jul;34(5):487-90.
  • Gammon B., Hansen C., Costner MI., A Comment on Mycophenolate Mofetil and Hydroxychloroquine: An Effective Treatment for Recalcitrant Cutaneous Lupus Erythematosus. J Amer Acad Dermatol. 2012 Jan;66(1):161-2.
  • Gammon B., Beilfuss B., Guitart J., Gerami P., Enhanced detection of spitzoid melanomas using fluorescence in situ hybridization with 9p21 as an adjunctive probe. Amer J Surg Pathol. 2012 Jan;36(1):81-8.
  • Gammon B., Kamalpour L., Chen K.H., et al., Resource utilization and quality of life in the congenital ichthyoses. Pediatr Dermatol. 2011 Sep-Oct;28(5):512-8
  • Gammon B., Hansen C., Costner MI., Efficacy of Mycophenolate Mofetil in Antimalarial-resistant Cutaneous Lupus Erythematosus. J Amer Acad Dermatol. 2011 Oct;65(4):717-21.
  • Gammon B., Beilfuss B., et al. Fluorescence in situ hybridization for distinguishing atypical cellular blue nevi from malignant blue nevi. J Cutan Pathol. 2011 Apr;38(4):335-41
  • DeLong LK, Wetherington S, Hill N, Kumari M, Gammon Bet al. Vitamin D levels, dietary intake, and photoprotective behaviors among patients with skin cancer. Semin Cutan Med Surg. 2010 Sep;29(3):185-9.
  • Gammon B., Gleason BC, Thomas AB, Cibull T. Sarcomatoid Renal Cell Carcinoma Presenting in the Oropharynx. J Cutan Pathol. 2010 Dec;37(12):1255-8
  • Gammon B., McDermott D., et al. Autosomal dominant epidermodysplasia verruciformis lacking a known EVER1 or EVER2 mutation. Pediatr Dermatol. 2009 May-Jun;26(3):306-10.
  • Kamalpour L., Gammon B.et al. Granuloma faciale associated with basal cell carcinoma. J Cutan Pathol. 2009 Oct;36(10):1103-4.
Book Chapters & Articles
  • Schlosser B, Gammon B. Perioral Dermatitis. In: Acneiform Eruptions: A Differential Diagnosis. J. Zeichner ed. New York, NY: Springer Clinical Medicine. (in press)
  • Gammon B. Cutaneous Manifestations of Sexually Transmitted Disease in the HIV-Positive Patient. In: Cutaneous Manifestations of HIV Disease. C. Cockerell and A. Calame eds. Manson Publishing Ltd., 2012.
  • Gerami P, Gammon B, Murphy, M. Melanocytic neoplasms I: Molecular diagnosis. In: Molecular Diagnostics in Dermatology and Dermatopathology. M. Murphy ed. Totowa, NJ: Humana Press, 2011.
  • Gammon B. “The Shoes Tell the Tale.” The New Physician. Dec 2006 pp. 19-20.
Poster Presentations
  • Gammon B., Guitart, J. “Intertriginous mycosis fungoides: a unique demblee presentation of CTCL with a poor outcome” (abstract)
    48th American Society of Dermatopathology Annual Meeting, Seattle, WA.
  • Gammon B., Gerami P. “Fluorescence in situ hybridization for distinguishing malignant blue nevi from atypical cellular blue nevi” (abstract) J Invest Dermatol 2010; 130:S143 S1.
    70th Society for Investigative Dermatology Annual Meeting, Atlanta, GA.
  • Hughes S., Gammon B., Bohlke A., et al. ”Nested melanocytic hyperplasia mimicking lentigo maligna in interface dermatitis, a series of five cases” (abstract)
    46th American Society of Dermatopathology Annual Meeting, Chicago, IL.
  • Gammon B., Hughes S, Zhang J., et al. “Giant calcified and ulcerated collagenoma with associated smooth muscle proliferation” (abstract)
    46th American Society of Dermatopathology Annual Meeting, Chicago, IL.
  • Gammon B., Lee V., Hwang S.T. “Development of a novel chimeric fusion protein to identify CCR10+ cells” (abstract) J Invest Dermatol 2009; 129:S15 S1.
    69th Society for Investigative Dermatology Annual Meeting, Montreal, QC.
  • Hill N., Delong L., Tangpricha V., Gammon B., et al, “Vitamin D Levels and photoprotective behavior in patients with NMSC” (abstract) J Invest Dermatol 2009; 129:S65 S1.
    69th Society for Investigative Dermatology Annual Meeting, Montreal, QC.
  • Gammon B., “Hickam’s Dictum” (abstract) Journal of General Internal Medicine 2009; 24:317 S1.
    Society for Hospitalist Medicine Chicago, IL.
  • Gammon B., Hefler H., Richey L. “Take My Breath Away” (abstract) Journal of General Internal Medicine 24:378 S1 April 2009.
    32nd Society for General Internal Medicine Annual Meeting, May, 2009.
Oral Presentations/Lectureships
  • Gammon B., Deonizio J., Arkin L., Guitart J., “CD8+ Granulomatous cutaneous T cell lymphoma: a marker of immunodeficiency?” 49th American Society of Dermatopathology Annual Meeting, Fellows’ Case Presentations, Chicago, IL.
  • Gammon B., “Dermatology and skin disorders for primary care physicians” St. Catherine Hospital, East Chicago, IN, 5/3/12
  • Gammon B., “Great cases from Botswana” Grand Rounds, Northwestern University Department of Dermatology, Chicago, IL, 12/14/2011.
  • Gammon B., “The practice of dermatology in Botswana” Grand Rounds, Loyola University Department of Medicine, Division of Dermatology, Maywood, IL, 10/26/2011.
  • Gammon B., Beilfuss B., Guitart J., Gerami P., “Enhanced detection of spitzoid melanomas using fluorescence in situ hybridization with 9p21 as an adjunctive probe.” 70th American Academy of Dermatology Annual Meeting, Resident and Fellows Symposium, San Diego, CA.
  • Gammon B., Mancini A., “Stellate hyperpigmented patches on the legs: Macular Lymphocytic Arteritis.” 70th American Academy of Dermatology Annual Meeting, Gross and Microscopic Symposium, San Diego, CA.
  • Gammon B., Kundu R., “Subcorneal pustular dermatosis treated successfully with dapsone” 69th American Academy of Dermatology Annual Meeting, Gross and Microscopic Symposium, New Orleans, LA.
  • Gammon B., Beilfuss B., Gerami P., “Fluorescence in situ hybridization for distinguishing atypical cellular blue nevi from malignant blue nevi” Midwest Clinical Research Seminar and Symposium, Chicago, IL.
  • Kamalpour L., Gammon B., Chen K.H., et al, “Resource utilization and quality of life in the congenital ichthyoses.” (abstract) J Invest Dermatol 2009; 129:S63 S1. 69th Society for Investigative Dermatology Annual Meeting Montreal, QC.